The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis

AIDS Research and Treatment

Volumn 2014, Issue , 2014, Pages

  Van Galen, Katy A ^a   Nellen, Jeannine F ^a   Nieuwkerk, Pythia T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84921940362     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2014/967073     Document Type: Review

References (31)

1. S. Mannheimer, G. Friedland, J. Matts, C. Child, and M. Chesney, "The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials, " Clinical Infectious Diseases, vol. 34, no. 8, pp. 1115-1121, 2002.
2. V. D. Lima, R. Harrigan, D. R. Bangsberg et al., "The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time," Journal of Acquired Immune Deficiency Syndromes, vol. 50, no. 5, pp. 529-536, 2009.
3. T. R. Glass, M. Battegay, M. Cavassini et al., "Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: swiss HIV cohort study, " Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 2, pp. 197-203, 2010.
4. C. Protopopescu, F. Raffi, P. Roux et al., "Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data, " Journal of Antimicrobial Chemotherapy, vol. 64, no. 3, pp. 599-606, 2009.
5. M. Lazo, S. J. Gange, T. E. Wilson et al., "Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women, " Clinical Infectious Diseases, vol. 45, no. 10, pp. 1377-1385, 2007.
6. A. Ammassari, M. P. Trotta, R. Murri et al., "Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature, " Journal of Acquired Immune Deficiency Syndromes, vol. 31, supplement 3, pp. S123-S127, 2002.
7. V. E. Stone, J. Jordan, J. Tolson, R. Miller, and T. Pilon, "Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence, " Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 3, pp. 808-816, 2004.
8. J. B. Nachega, M. J. Mugavero, M. Zeier, M. Vitoria, and J. E. Gallant, "Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs, " Patient Preference and Adherence, vol. 5, pp. 357-367, 2011.
9. J.-J. Parienti, D. R. Bangsberg, R. Verdon, and E. M. Gardner, "Better adherence with once-daily antiretroviral regimens: a meta-analysis, " Clinical Infectious Diseases, vol. 48, no. 4, pp. 484-488, 2009.
10. B. Gazzard, C. Moecklinghoff, and A. Hill, "New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom, " ClinicoEconomics and Outcomes Research, vol. 4, no. 1, pp. 193-200, 2012.
11. M. Stoll, C. Kollan, F. Bergmann et al., "Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv Cohort, " PLoS ONE, vol. 6, no. 9, Article ID e23946, 2011.
12. G. L. Colombo, S. di Matteo, and F. Maggiolo, "Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen, " ClinicoEconomics and Outcomes Research, vol. 5, no. 1, pp. 59-68, 2013.
13. R. P. Walensky, P. E. Sax, Y. M. Nakamura et al., "Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States, " Annals of Internal Medicine, vol. 158, no. 2, pp. 84-92, 2013.
14. J. M. Llibre, J. R. Arribas, P. Domingo et al., "Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy, " AIDS, vol. 25, no. 14, pp. 1683-1690, 2011.
15. J. J. Eron, E. S. Yetzer, and P. J. Ruane, "Efficacy, safety, andadherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection, " AIDS, vol. 14, no. 6, pp. 671-681, 2000.
16. N. Sosa, C. Hill-Zabala, E. DeJesus et al., "Abacavir and lamivudine fixed-dose combination tablet once daily compared with abacavir and lamivudine twice daily in HIV-infected patients over 48 weeks (ESS30008, SEAL), " Journal of Acquired Immune Deficiency Syndromes, vol. 40, no. 4, pp. 422-427, 2005.
17. L. J. Geiter, R. J. OBrien, D. L. Combs, and D. E. Snider Jr., "United States PublicHealth Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide, " Tubercle, vol. 68, no. 2, pp. 41-46, 1987.
18. W.-J. Su and R.-P. Perng, "Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up, " International Journal of Tuberculosis and Lung Disease, vol. 6, no. 11, pp. 1029-1032, 2002.
19. Research Committee of the Tuberculosis Association of India, "Fifth tuberculosis association of India: short course chemotherapy trial, " Indian Journal of Tuberculosis, vol. 36, no. 2, pp. 95-101, 1989.
20. J. Asplund, M. Danielson, and P. Ohman, "Patients compliance in hypertension-the importance of number of tablets, " British Journal of Clinical Pharmacology, vol. 17, no. 5, pp. 547-552, 1984.
21. S. Bangalore, G. Kamalakkannan, S. Parkar, and F. H. Messerli, "Fixed-dose combinations improve medication compliance: a meta-analysis, " The American Journal of Medicine, vol. 120, no. 8, pp. 713-719, 2007.
22. J. P. A. Ioannidis, A.-B. Haidich, M. Pappa et al., "Comparison of evidence of treatment effects in randomized and nonrandomized studies, " The Journal of the American Medical Association, vol. 286, no. 7, pp. 821-830, 2001.
23. B. C. Reeves, J. J. Deeks, J. P. T. Higgins, and G. A. Wells, "Including non-randomized studies, " in CochraneHandbook for Systematic Reviews of Interventions Version 5. 1. 0, J. P. T. Higgins and S. Green, Eds., chapter 13, 2011.
24. M. Airoldi, M. Zaccarelli, L. Bisi et al., "One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects, " Patient Preference and Adherence, vol. 4, pp. 115-125, 2010.
25. F. Engsig, J. Gerstoft, M. Helleberg, G. Kronborg, L. Mathiesen, and N. Obel, "Virologica l response in patients who for economic reasons were changed from Atripla to a multitablet cART regimen, " in Proceedings of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 13), Atlanta, Ga, USA, March 2013, Abstract 579.
26. G. A. Rao, S. S. Sutton, J. Hardin et al., "Impact of highly active antiretroviral therapy regimen on adherence and risk of hospitalization in veterans with HIV/AIDS, " in Proceedings of the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 13), Denver, Colo, USA, September 2013, Abstract H-1464.
27. C. J. Cohen, J. L. Meyers, and K. L. Davis, "Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US Medicaid population with HIV, " BMJ Open, vol. 3, Article ID e003028, 2013.
28. S. Kapadia, R. Grant, and S. Hodder, "Virologic response better with single tablet fixed dose antiretroviral regimens compared with multiple tablet regimens in an urban population of HIVinfected persons, " in Proceedings of the IDWeek, Advancing Science, Improving Care, Abstract 168, San Francisco, Calif, USA, October 2013.
29. A. Buscher, C. Hartman, M. A. Kallen, and T. P. Giordano, "Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients, " International Journal of STD and AIDS, vol. 23, no. 5, pp. 351-355, 2012.
30. J. A. Bartlett, R. DeMasi, J. Quinn, C. Moxham, and F. Rousseau, "Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults, " AIDS, vol. 15, no. 11, pp. 1369-1377, 2001.
31. J. B. Nachega, J. J. Parienti, O. A. Uthman et al., "Lower pill burden and once-daily antiretroviral treatment regimens for hiv infection: a meta-analysis of randomized controlled trials, " Clinical Infectious Diseases, vol. 58, pp. 1297-1307, 2014.